Zoom Video Communications (ZM) 10-Q23 Aug 232024 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Jul. 31, 2023	Aug. 11, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	001-38865
Entity Registrant Name	Zoom Video Communications, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	61-1648780
Entity Address, Address Line One	55 Almaden Boulevard
Entity Address, Address Line Two	6th Floor
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95113
City Area Code	888
Local Phone Number	799-9666
Title of 12(b) Security	Class A Common Stock, $0.001 par value per share
Trading Symbol	ZM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001585521
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		254,292,343
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		46,664,611

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,380,121	$ 1,086,830
Marketable securities	4,648,393	4,325,836
Accounts receivable, net of allowances of $45,781 and $33,206 as of July 31, 2023 and January 31, 2023, respectively	571,049	557,404
Deferred contract acquisition costs, current	207,165	223,250
Prepaid expenses and other current assets	244,264	163,092
Total current assets	7,050,992	6,356,412
Deferred contract acquisition costs, noncurrent	150,260	179,991
Property and equipment, net	275,881	252,821
Operating lease right-of-use assets	70,249	80,906
Strategic investments	376,693	398,992
Goodwill	307,295	122,641
Deferred tax assets	541,016	558,428
Other assets, noncurrent	150,722	177,874
Total assets	8,923,108	8,128,065
Current liabilities:
Accounts payable	20,854	14,414
Accrued expenses and other current liabilities	397,268	457,716
Deferred revenue, current	1,349,351	1,266,514
Total current liabilities	1,767,473	1,738,644
Deferred revenue, noncurrent	20,417	41,932
Operating lease liabilities, noncurrent	62,181	73,687
Other liabilities, noncurrent	70,685	67,195
Total liabilities	1,920,756	1,921,458
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value per share, 200,000,000 shares authorized as of July 31, 2023 and January 31, 2023; zero shares issued and outstanding as of July 31, 2023 and January 31, 2023	0	0
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of July 31, 2023 and January 31, 2023; 254,291,416 and 247,151,956 shares issued and outstanding as of July 31, 2023 and January 31, 2023, respectively; 300,000,000 Class B shares authorized as of July 31, 2023 and January 31, 2023; 46,664,611 and 46,670,894 shares issued and outstanding as of July 31, 2023 and January 31, 2023, respectively	302	294
Additional paid-in capital	4,689,521	4,104,880
Accumulated other comprehensive loss	(36,707)	(50,385)
Retained earnings	2,349,236	2,151,818
Total stockholders’ equity	7,002,352	6,206,607
Total liabilities and stockholders’ equity	$ 8,923,108	$ 8,128,065

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Accounts receivable, allowances	$ 45,781	$ 33,206
Stockholders’ equity:
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Class A Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, issued (in shares)	254,291,416	247,151,956
Common stock, outstanding (in shares)	254,291,416	247,151,956
Class B Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	46,664,611	46,670,894
Common stock, outstanding (in shares)	46,664,611	46,670,894

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Statement [Abstract]
Revenue	$ 1,138,676	$ 1,099,458	$ 2,244,040	$ 2,173,258
Cost of revenue	266,559	273,611	530,506	535,432
Gross profit	872,117	825,847	1,713,534	1,637,826
Operating expenses:
Research and development	191,802	172,564	401,073	316,855
Sales and marketing	373,373	400,474	795,877	763,257
General and administrative	129,324	131,066	329,224	248,906
Total operating expenses	694,499	704,104	1,526,174	1,329,018
Income from operations	177,618	121,743	187,360	308,808
Gains (losses) on strategic investments, net	31,670	(34,712)	33,945	(71,116)
Other income (expense), net	41,085	3,368	72,298	(3,621)
Income before provision for income taxes	250,373	90,399	293,603	234,071
Provision for income taxes	68,399	44,649	96,185	74,663
Net income	181,974	45,750	197,418	159,408
Undistributed earnings attributable to participating securities	0	(4)	0	(19)
Net income attributable to common stockholders	$ 181,974	$ 45,746	$ 197,418	$ 159,389
Net income per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.61	$ 0.15	$ 0.66	$ 0.53
Diluted (in dollars per share)	$ 0.59	$ 0.15	$ 0.65	$ 0.52
Weighted-average shares used in computing net income per share attributable to common stockholders:
Basic (in shares)	299,093,452	298,553,379	297,281,846	298,865,676
Diluted (in shares)	305,932,596	307,160,840	305,054,771	306,902,964

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 181,974	$ 45,750	$ 197,418	$ 159,408
Other comprehensive (loss) income:
Unrealized gain (loss) on available-for-sale marketable securities, net of income tax (expense) benefit of $553 and $929 for the three months ended July 31, 2023 and 2022, respectively, and $(4,121) and $9,615 for the six months ended July 31, 2023 and 2022, respectively	(1,836)	(2,924)	13,678	(30,259)
Comprehensive income	$ 180,138	$ 42,826	$ 211,096	$ 129,149

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Unrealized (loss) gain on available for sale marketable securities, tax effect	$ 553	$ 929	$ (4,121)	$ 9,615

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Jan. 31, 2022		299,037,805
Beginning balance at Jan. 31, 2022	$ 5,780,018	$ 299	$ 3,749,514	$ (17,902)	$ 2,048,107
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		858,055
Issuance of common stock upon exercise of stock options	5,243	$ 1	5,242
Issuance of common stock upon release of restricted stock units (in shares)		1,906,359
Issuance of common stock upon release of restricted stock units	0	$ 2	(2)
Issuance of common stock for employee stock purchase plan (in shares)		373,259
Issuance of common stock for employee stock purchase plan	34,604		34,604
Repurchase of common stock (in shares)		(4,088,971)
Repurchases of common stock	(425,946)	$ (4)	(425,942)
Stock-based compensation expense	467,329		467,329
Other comprehensive income (loss)	(30,259)			(30,259)
Net income	159,408				159,408
Ending balance (in shares) at Jul. 31, 2022		298,086,507
Ending balance at Jul. 31, 2022	5,990,397	$ 298	3,830,745	(48,161)	2,207,515
Beginning balance (in shares) at Apr. 30, 2022		298,824,233
Beginning balance at Apr. 30, 2022	5,947,887	$ 299	3,831,060	(45,237)	2,161,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		314,537
Issuance of common stock upon exercise of stock options	1,899		1,899
Issuance of common stock upon release of restricted stock units (in shares)		1,439,199
Issuance of common stock upon release of restricted stock units	0	$ 2	(2)
Issuance of common stock for employee stock purchase plan (in shares)		373,259
Issuance of common stock for employee stock purchase plan	34,604		34,604
Repurchase of common stock (in shares)		(2,864,721)
Repurchases of common stock	(293,534)	$ (3)	(293,531)
Stock-based compensation expense	256,715		256,715
Other comprehensive income (loss)	(2,924)			(2,924)
Net income	45,750				45,750
Ending balance (in shares) at Jul. 31, 2022		298,086,507
Ending balance at Jul. 31, 2022	5,990,397	$ 298	3,830,745	(48,161)	2,207,515
Beginning balance (in shares) at Jan. 31, 2023		293,822,850
Beginning balance at Jan. 31, 2023	$ 6,206,607	$ 294	4,104,880	(50,385)	2,151,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,044,922	1,044,922
Issuance of common stock upon exercise of stock options	$ 7,686	$ 1	7,685
Issuance of common stock upon release of restricted stock units (in shares)		5,535,351
Issuance of common stock upon release of restricted stock units	0	$ 6	(6)
Issuance of common stock for employee stock purchase plan (in shares)		552,904
Issuance of common stock for employee stock purchase plan	32,513	$ 1	32,512
Stock-based compensation expense	544,450		544,450
Other comprehensive income (loss)	13,678			13,678
Net income	197,418				197,418
Ending balance (in shares) at Jul. 31, 2023		300,956,027
Ending balance at Jul. 31, 2023	7,002,352	$ 302	4,689,521	(36,707)	2,349,236
Beginning balance (in shares) at Apr. 30, 2023		297,455,726
Beginning balance at Apr. 30, 2023	6,524,107	$ 298	4,391,418	(34,871)	2,167,262
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		542,954
Issuance of common stock upon exercise of stock options	3,417		3,417
Issuance of common stock upon release of restricted stock units (in shares)		2,404,443
Issuance of common stock upon release of restricted stock units	0	$ 3	(3)
Issuance of common stock for employee stock purchase plan (in shares)		552,904
Issuance of common stock for employee stock purchase plan	32,513	$ 1	32,512
Stock-based compensation expense	262,177		262,177
Other comprehensive income (loss)	(1,836)			(1,836)
Net income	181,974				181,974
Ending balance (in shares) at Jul. 31, 2023		300,956,027
Ending balance at Jul. 31, 2023	$ 7,002,352	$ 302	$ 4,689,521	$ (36,707)	$ 2,349,236

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities:
Net income	$ 197,418	$ 159,408
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	543,854	464,878
Amortization of deferred contract acquisition costs	138,744	119,502
Depreciation and amortization	50,202	36,155
Deferred income taxes	13,975	0
(Gains) losses on strategic investments, net	(33,945)
(Gains) losses on strategic investments, net		71,116
Provision for accounts receivable allowances	22,204	26,727
Unrealized foreign exchange losses	4,683	19,472
Non-cash operating lease cost	10,657	11,067
Amortization of discount/premium on marketable securities	(18,014)	4,821
Other	(3,415)	(167)
Changes in operating assets and liabilities:
Accounts receivable	13,631	(125,898)
Prepaid expenses and other assets	(83,888)	(136,619)
Deferred contract acquisition costs	(92,927)	(157,005)
Accounts payable	4,999	16,441
Accrued expenses and other liabilities	(58,951)	64,262
Deferred revenue	56,332	220,550
Operating lease liabilities, net	(11,101)	(11,350)
Net cash provided by operating activities	754,458	783,360
Cash flows from investing activities:
Purchases of marketable securities	(1,826,166)	(1,576,853)
Maturities of marketable securities	1,543,120	1,306,676
Purchases of property and equipment	(68,426)	(52,870)
Purchases of strategic investments	(51,000)	(61,550)
Proceeds from strategic investments	107,244	0
Cash paid for acquisition, net of cash acquired	(204,918)	(120,553)
Purchases of intangible assets	0	(3,211)
Net cash used in investing activities	(500,146)	(508,361)
Cash flows from financing activities:
Proceeds from exercise of stock options	7,686	5,065
Proceeds from issuance of common stock for employee stock purchase plan	32,513	34,605
Proceeds from employee equity transactions to be remitted (remitted) to employees and tax authorities, net	1,259	(2,545)
Cash paid for repurchases of common stock	0	(425,946)
Net cash provided by (used in) financing activities	41,458	(388,821)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(3,781)	(16,111)
Net increase (decrease) in cash, cash equivalents, and restricted cash	291,989	(129,933)
Cash, cash equivalents, and restricted cash – beginning of period	1,100,243	1,073,353
Cash, cash equivalents, and restricted cash – end of period	1,392,232	943,420
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	1,380,121	937,443
Restricted cash, current included in prepaid expenses and other current assets	11,856	5,708
Restricted cash, noncurrent included in other assets, noncurrent	255	269
Total cash, cash equivalents, and restricted cash	$ 1,392,232	$ 943,420

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	6 Months Ended
Summary of Business and Significant Accounting Policies	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Description of Business Zoom Video Communications, Inc. and its subsidiaries (collectively, “Zoom,” the “Company,” “we,” “us,” or “our”) connect people through our core unified communications and collaboration platform, which frictionlessly brings together video, phone, chat, webinars events, and contact center, and enables meaningful experiences across disparate devices and locations. We were incorporated in the state of Delaware in April 2011, and are headquartered in San Jose, California. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of operations, statements of comprehensive income, statements of stockholders’ equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2023, filed with the SEC on March 3, 2023. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, stock-based compensation expense, the fair value of marketable securities, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates. Summary of Significant Accounting Policies Our significant accounting policies are discussed in Note 1. “Summary of Business and Significant Accounting Policies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023, filed with the SEC on March 3, 2023. There have been no significant changes to these policies during the six months ended July 31, 2023.

Revenue Recognition

Revenue Recognition	6 Months Ended
Revenue Recognition	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following table summarizes revenue by region based on the billing address of customers: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Amount Percentage of Amount Percentage of Amount Percentage of Amount Percentage of (in thousands, except percentages) Americas $ 808,425 71 % $ 762,690 69 % $ 1,593,022 71 % $ 1,491,071 69 % Asia Pacific (“APAC”) 144,915 13 149,355 14 285,786 13 298,175 14 Europe, Middle East, and Africa (“EMEA”) 185,336 16 187,413 17 365,232 16 384,012 17 Total $ 1,138,676 100 % $ 1,099,458 100 % $ 2,244,040 100 % $ 2,173,258 100 % Contract Balances We receive payments from customers based on a billing schedule as established in our customer contracts. Accounts receivable are recorded when we contractually have the right to consideration. In some arrangements, a right to consideration for our performance under the customer contract may occur before invoicing to the customer, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net was $115.6 million and $91.6 million as of July 31, 2023 and January 31, 2023, respectively, and the amount of unbilled accounts receivable included within other assets, noncurrent was immaterial as of July 31, 2023 and January 31, 2023. Contract liabilities consist of deferred revenue. Revenue is deferred when we have the right to invoice in advance of performance under a customer contract. The current portion of deferred revenue balances is recognized over the next 12 months. The amount of revenue recognized during the three months ended July 31, 2023 and 2022 that was included in deferred revenue at the beginning of each period was $593.9 million and $572.7 million, respectively, and $939.2 million and $867.6 million during the six months ended July 31, 2023 and 2022, respectively. Remaining Performance Obligations The terms of our subscription agreements are monthly, annual, and multiyear, and we may bill for the full term in advance or on an annual, quarterly, or monthly basis, depending on the billing terms with customers. As of July 31, 2023, the aggregate amount of the transaction price allocated to our remaining performance obligations was $3,504.4 million, which consists of both billed consideration in the amount of $1,369.8 million and unbilled consideration in the amount of $2,134.6 million that we expect to recognize as revenue. We expect to recognize 59% of our remaining performance obligations as revenue over the next 12 months and the remainder thereafter.

Investments

Investments	6 Months Ended
Investments	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Marketable Securities As of July 31, 2023 and January 31, 2023, our marketable securities consisted of the following: As of July 31, 2023 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 67,269 $ — $ — $ 67,269 Agency bonds 1,445,880 7 (15,588) 1,430,299 Corporate and other debt securities 543,042 68 (4,635) 538,475 U.S. government agency securities 2,590,023 10 (28,254) 2,561,779 Treasury bills 50,596 — (25) 50,571 Marketable securities $ 4,696,810 $ 85 $ (48,502) $ 4,648,393 As of January 31, 2023 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 77,701 $ — $ — $ 77,701 Agency bonds 823,027 63 (12,440) 810,650 Corporate and other debt securities 555,354 385 (4,845) 550,894 U.S. government agency securities 2,910,572 150 (49,507) 2,861,215 Treasury bills 25,404 1 (29) 25,376 Marketable securities $ 4,392,058 $ 599 $ (66,821) $ 4,325,836 Unrealized losses for securities that have been in an unrealized loss position for less than 12 months were $25.2 million and $24.8 million as of July 31, 2023 and January 31, 2023, respectively. Unrealized losses for securities that have been in an unrealized loss position for 12 months or longer were $23.3 million and $42.0 million as of July 31, 2023 and January 31, 2023, respectively. We review the individual securities that have unrealized losses on a regular basis to evaluate whether or not any security has experienced, or is expected to experience, credit losses resulting in the decline in fair value. We evaluate, among other factors, whether we have the intention to sell any of these marketable securities and whether it is more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high-grade credit rating for each of our marketable securities as of the end of each period. There were no material realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive loss for the three and six months ended July 31, 2023 and 2022. The following table presents the contractual maturities of our marketable securities as of July 31, 2023 and January 31, 2023: As of July 31, 2023 January 31, 2023 (in thousands) Less than one year $ 2,757,001 $ 2,743,677 Due in one to five years 1,891,392 1,582,159 Total $ 4,648,393 $ 4,325,836 Strategic Investments Strategic investments by form and measurement category as of July 31, 2023 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 92,139 $ 185,732 $ 95,070 $ 372,941 Debt securities 3,752 — — 3,752 Strategic investments $ 95,891 $ 185,732 $ 95,070 $ 376,693 Strategic investments by form and measurement category as of January 31, 2023 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 171,975 $ 118,763 $ 93,854 $ 384,592 Debt securities 14,400 — — 14,400 Strategic investments $ 186,375 $ 118,763 $ 93,854 $ 398,992 In the first quarter of fiscal year 2024, we made a total of $51.0 million of strategic investments in equity securities of private companies. Based on the terms of these privately-held securities, we determined that we do not have a controlling interest nor the ability to exercise significant influence over the operating and financial policies of the investees. Therefore these investments are currently accounted for under the measurement alternative method. In the second quarter of fiscal year 2024, we sold a total of $107.2 million of strategic investments in equity securities of public companies. The gains on sale, which were not material, were recorded through gains (losses) on strategic investments, net in the condensed consolidated statements of operations.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
Fair Value Measurements	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: As of July 31, 2023 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 801,409 $ 801,409 $ — $ — Treasury bills 71,187 — 71,187 — Cash equivalents 872,596 801,409 71,187 — Commercial paper 67,269 — 67,269 — Agency bonds 1,430,299 — 1,430,299 — Corporate and other debt securities 538,475 — 538,475 — U.S. government agency securities 2,561,779 — 2,561,779 — Treasury bills 50,571 — 50,571 — Marketable securities 4,648,393 — 4,648,393 — Certificates of deposit included in other assets, noncurrent 255 — 255 — Publicly held equity securities included in strategic investments 92,139 92,139 — — Privately held debt securities included in strategic investments 3,752 — — 3,752 Total financial assets $ 5,617,135 $ 893,548 $ 4,719,835 $ 3,752 As of January 31, 2023 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 310,571 $ 310,571 $ — $ — Cash equivalents 310,571 310,571 — — Commercial paper 77,701 — 77,701 — Agency bonds 810,650 — 810,650 — Corporate and other debt securities 550,894 — 550,894 — U.S. government agency securities 2,861,215 — 2,861,215 — Treasury bills 25,376 — 25,376 — Marketable securities 4,325,836 — 4,325,836 — Certificates of deposit included in other assets, noncurrent 272 — 272 — Publicly held equity securities included in strategic investments 171,975 171,975 — — Privately held debt securities included in strategic investments 14,400 — — 14,400 Total financial assets $ 4,823,054 $ 482,546 $ 4,326,108 $ 14,400 We classify our highly liquid money market funds and publicly held equity securities within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify our commercial paper, agency bonds, corporate and other debt securities, U.S. government agency securities, treasury bills, and certificates of deposit within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security, which may not be actively traded. We classify our privately held debt securities as Level 3 due to the lack of relevant observable market data over fair value inputs, such as the probability weighting of the various scenarios that can impact settlement of the arrangement.

Business Combinations

Business Combinations	6 Months Ended
Business Combinations	Jul. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Solvvy, Inc. On May 19, 2022, we acquired 100% of the issued and outstanding share capital of Solvvy, Inc., a private technology company specializing in customer support automation, for an all-cash purchase consideration of $121.2 million. The acquisition adds to our customer service capabilities and enhances our integrated platform by providing conversational AI capabilities. The acquisition has been accounted for as a business combination. In allocating the purchase consideration, $95.0 million was attributed to goodwill, $26.7 million to intangible assets (consisted of $12.0 million to developed technology and $14.7 million to customer relationships), and $0.5 million to other net liabilities acquired. The goodwill amount represents synergies related to our existing products expected to be realized from the acquisition and assembled workforce. The associated goodwill is not deductible for tax purposes. At the date of the acquisition, the developed technology and customer relationships both had an estimated useful life of 5.0 years, and both are amortized using the straight-line method over their respective estimated useful lives. As of July 31, 2023, the developed technology and customer relationships both had a remaining useful life of 3.8 years. Transaction costs incurred in connection with the acquisition were immaterial. The results of operations of Solvvy, Inc., which are not material, have been included in our condensed consolidated financial statements from the date of the acquisition. Pro forma and historical results of operations of the company have not been presented, as the results do not have a material effect on any of the periods presented in our condensed consolidated statements of operations. Workvivo Limited On April 21, 2023, we acquired 100% of the issued and outstanding share capital of Workvivo Limited (“Workvivo”), a private technology company that provides an employee experience platform, for an all-cash purchase consideration of $221.8 million. The acquisition extends our platform and offers our customers new ways to keep employees informed, engaged, and connected. The acquisition has been accounted for as a business combination. In allocating the purchase consideration, $184.7 million was attributed to goodwill, $28.0 million to intangible assets (primarily consisting of $10.8 million to developed technology and $17.0 million to customer relationships), and $9.1 million to other net assets acquired. The goodwill amount represents synergies related to our existing products expected to be realized from the acquisition and assembled workforce. The associated goodwill is not deductible for tax purposes. At the date of the acquisition, the developed technology and customer relationships both had an estimated useful life of 5.0 years, and both are amortized using the straight-line method over their respective estimated useful lives. As of July 31, 2023, the developed technology and customer relationships both had a remaining useful life of 4.7 years. Transaction costs incurred in connection with the acquisition were immaterial. The results of operations of Workvivo, which are not material, have been included in our condensed consolidated financial statements from the date of the acquisition. Pro forma and historical results of operations of the company have not been presented, as the results do not have a material effect on any of the periods presented in our condensed consolidated statements of operations. Uncertain tax positions are initially established in connection with the acquisition as of the acquisition date. We continue to collect information and reevaluate these estimates and assumptions quarterly. We will record any adjustments to our preliminary estimates to goodwill, provided that it is within the one-year measurement period.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
Balance Sheet Components	Jul. 31, 2023
Balance Sheet Components [Abstract]
Balance Sheet Components	Balance Sheet Components Accounts Receivable, Net Accounts receivable are recorded for invoiced amounts and amounts for which revenue has been recognized, but not invoiced, net of allowances. Our short-term accounts receivable consist of the following: As of July 31, 2023 January 31, 2023 (in thousands) Accounts receivable, gross $ 616,830 $ 590,610 Less: allowance for credit losses (38,093) (24,900) Less: allowance for returns (7,688) (8,306) Accounts receivable, net $ 571,049 $ 557,404 Below is a rollforward of our allowance for credit losses for the six months ended July 31, 2023 and 2022: 2023 2022 (in thousands) Balance as of January 31 $ 24,900 $ 17,000 Provision for credit losses 30,250 25,606 Write-offs (17,057) (19,406) Balance as of July 31 $ 38,093 $ 23,200 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Prepaid expenses $ 204,768 $ 123,493 Other receivables 16,427 17,142 Restricted cash from international employee stock sales 11,856 13,141 Other 11,213 9,316 Prepaid expenses and other current assets $ 244,264 $ 163,092 Property and Equipment, Net Property and equipment consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Servers $ 303,527 $ 249,776 Software 89,872 84,082 Computer and office equipment 46,780 48,325 Leasehold improvements 30,863 25,948 Furniture and fixtures 4,449 4,372 Property and equipment, gross 475,491 412,503 Less: accumulated depreciation and amortization (199,610) (159,682) Property and equipment, net $ 275,881 $ 252,821 Depreciation and amortization expense was $22.6 million and $19.6 million for the three months ended July 31, 2023 and 2022, respectively, and $44.6 million and $34.7 million for the six months ended July 31, 2023 and 2022, respectively. Other Assets, Noncurrent Other assets, noncurrent consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Accounts receivable, noncurrent $ 41,820 $ 92,031 Intangible assets subject to amortization, net 53,832 31,420 Indefinite-lived intangible assets 25,239 25,239 Prepaid expenses, noncurrent 17,528 9,695 Other 12,303 19,489 Other assets, noncurrent $ 150,722 $ 177,874 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Accrued expenses $ 151,881 $ 160,189 Accrued compensation and benefits 111,791 139,105 Income tax liabilities 20,224 46,441 Sales and other non-income tax liabilities 30,968 33,859 Customer deposit liabilities 35,236 33,640 Operating lease liabilities, current 23,512 22,790 Other 23,656 21,692 Accrued expenses and other current liabilities $ 397,268 $ 457,716 Other Liabilities, Noncurrent Other liabilities, noncurrent consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Sales and other non-income tax liabilities $ 43,640 $ 42,321 Other 27,045 24,874 Other liabilities, noncurrent $ 70,685 $ 67,195

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations During the six months ended July 31, 2023, there have been no material changes to our non-cancelable purchase obligations from those disclosed in Note 8. “Commitments and Contingencies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023, filed with the SEC on March 3, 2023. Other Contingencies In June 2020, we received a grand jury subpoena from the Department of Justice’s U.S. Attorney’s Office for Eastern District of New York (“EDNY”), which requested information regarding our interactions with foreign governments and foreign political parties, including the Chinese government, as well as information regarding storage of and access to user data, the development and implementation of Zoom’s privacy policies, and the actions we took relating to the Tiananmen commemorations on Zoom. In July 2020, we received subpoenas from the Department of Justice’s U.S. Attorney’s Office for the Northern District of California (“NDCA”) and the SEC. Both subpoenas seek documents and information relating to various security, data protection and privacy matters, including our encryption, and our statements relating thereto, as well as calculation of usage metrics and related public statements. In addition, the NDCA subpoena seeks information relating to any contacts between our employees and representatives of the Chinese government, and any attempted or successful influence by any foreign government in our policies, procedures, practices, and actions as they relate to users in the United States. We have since received additional subpoenas from EDNY and NDCA seeking related information. We are fully cooperating with all of these investigations and have been conducting our own thorough internal investigation. These investigations are ongoing, and we do not know when they will be completed, which facts we will ultimately discover as a result of the investigations, or what actions the government may or may not take. We cannot predict the outcome of these investigations, and a negative outcome in any or all of these matters could cause us to incur substantial fines, penalties, or other financial exposure, as well as reputational harm. Legal Proceedings On June 11, 2020 and July 30, 2020, purported shareholder derivative complaints were filed in the United States District Court for the District of Delaware. The first complaint names as defendants nine of our officers and directors, and the second complaint names eight of our officers and directors. The lawsuits assert state and federal claims and are based on the same alleged misstatements as the shareholder class action complaint. The lawsuits accuse our board of directors of failing to exercise reasonable and prudent supervision over our management, policies, practices, and internal controls. The plaintiffs seek unspecified monetary damages on behalf of us as well as governance reforms. On September 25, 2020, the derivative cases were consolidated. On October 27, 2021, a third substantially identical lawsuit was filed in the same court against the same defendants, seeking unspecified monetary damages and governance reforms. On November 17, 2021, all three derivative lawsuits were consolidated. The consolidated case was stayed pending resolution of the motion to dismiss the securities class action. On April 11, 2023, the court entered a stipulated order that requires defendants to answer, move, or otherwise respond to the operative complaint by June 12, 2023. On June 12, 2023, defendants filed a motion to dismiss the consolidated case. On August 11, 2023, the plaintiff in the consolidated case filed an amended complaint. We are vigorously defending ourselves against these lawsuits. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, we cannot estimate the reasonably possible loss or range of loss that may result from these actions. Beginning on March 30, 2020, multiple putative class actions were filed against us in various U.S. federal district courts and state courts relating to our alleged privacy and security practices, including alleged data sharing with third parties (the “U.S. Privacy Class Actions”). The plaintiffs claim violations of a variety of state consumer protection and privacy laws, and also assert state constitutional and common law claims, such as negligence and unjust enrichment. The U.S. Privacy Class Actions seek to certify both nationwide and state-specific classes of individuals using our services in certain time periods. The plaintiffs seek various forms of injunctive and monetary relief, including restitution, statutory and actual damages, punitive damages, and attorneys’ fees. The federal cases have been transferred to and consolidated in the NDCA with our consent; lead plaintiffs’ counsel have been appointed; and plaintiffs filed their first amended consolidated class action complaint on October 28, 2020. On March 11, 2021, the court granted in part, and denied in part, our motion to dismiss, and gave plaintiffs leave to amend. On July 30, 2021, we entered into a settlement agreement with plaintiffs to settle the action on a classwide basis, and plaintiffs filed a motion for preliminary approval of the settlement with the court on July 31, 2021. On October 21, 2021, the Court preliminarily approved the settlement. Under the terms of the settlement, we have paid $85.0 million into an escrow account that will be used to pay claims filed by settlement class members, attorneys’ fees and expenses, administrative costs, and service payments to plaintiffs. On April 21, 2022, the Court granted final approval of the settlement. On May 19, 2022, two objectors to the settlement appealed the Court's final approval order. On May 20, 2022, a third objector appealed the Court’s final approval order. On October 17, 2022, we, plaintiffs, and all three objector-appellants agreed to settle the appeals, and on October 27, 2022, we and plaintiffs initiated proceedings in the district court to obtain Court approval of the settlements, which the district court approved on December 16, 2022. On January 13, 2023, a new objector appealed the court’s December 16, 2022 approval of the settlements of the prior appeals, and on March 31, 2023, the Ninth Circuit dismissed the new appeal. With the appeals resolved, the class action settlement is final and the settlement administrator is in the process of making payments to claimants. On April 7, 2020 and April 8, 2020, securities class action complaints were filed against us and two of our officers in the United States District Court for the NDCA. The plaintiffs are purported stockholders of ours. The complaints allege, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 by making false and misleading statements and omissions of material fact about our data privacy and security measures. The complaints seek unspecified damages, interest, fees, and costs. On May 18, 2020, the actions were consolidated. On November 4, 2020, the court appointed a lead plaintiff. On December 23, 2020, the lead plaintiff filed a consolidated complaint. We filed a motion to dismiss the consolidated complaint on May 20, 2021. Plaintiff filed an opposition to our motion to dismiss on July 9, 2021. Our reply in support of the motion to dismiss was filed on August 9, 2021. On February 16, 2022, the court granted in part, and denied in part, our motion to dismiss. On March 14, 2022, we moved for reconsideration of the court’s ruling on the motion to dismiss. On March 22, 2022, the court ordered plaintiff to respond to our motion, which plaintiff did on March 29, 2022. On April 22, 2022, we answered the complaint. On March 8, 2023, the court denied our motion for reconsideration. On April 6, 2023, the court entered a scheduling order. On July 17, 2023, the parties entered into a stipulation and agreement of settlement (the “Stipulation”) to resolve this matter. Under the terms of the stipulation, in exchange for the release and dismissal with prejudice of all claims against all defendants in the matter, we have agreed to pay and/or cause our insurance carriers to pay a total of $150.0 million. The Stipulation and settlement remain subject to preliminary and final approval by the court. On July 25, 2023, the court entered an order staying further proceedings in the matter pending the filing of a motion for preliminary approval of the settlement, which is to be filed no later than October 20, 2023. As a result of the settlement, we made net payments of $60.0 million ($150.0 million for the settlement net of $90.0 million covered by insurance) during the three months ended July 31, 2023, of which $7.5 million had been accrued during the year ended January 31, 2023 and $52.5 million was recorded as a

Stockholders_ Equity and Equity

Stockholders’ Equity and Equity Incentive Plans	6 Months Ended
Stockholders’ Equity and Equity Incentive Plans	Jul. 31, 2023
Stockholders' Equity Note [Abstract]
Stockholders’ Equity and Equity Incentive Plans	Stockholders’ Equity and Equity Incentive Plans Common Stock Our amended and restated certificate of incorporation authorizes the issuance of 2,000,000,000 shares of Class A common stock, $0.001 par value per share, and 300,000,000 shares of Class B common stock, $0.001 par value per share. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. Stock Repurchase Plan In February 2022, our Board of Directors authorized a stock repurchase program of up to $1.0 billion of our Class A common stock, which was completed in December 2022. During the three and six months ended July 31, 2022, we repurchased and subsequently retired 2,864,721 and 4,088,971 shares of our Class A common stock, respectively, for an aggregate amount of $293.5 million and $425.9 million, respectively. Equity Incentive Plans We have two equity incentive plans: the 2011 Global Share Plan (“2011 Plan”) and the 2019 Equity Incentive Plan (“2019 Plan”). All shares that remain available for future grants are under the 2019 Plan. Stock Options A summary of stock option activity under our equity incentive plan and related information is as follows: Stock Options Outstanding Weighted- Weighted- Aggregate (in thousands, except share, life, and per share data) Balance as of January 31, 2023 4,800,616 $ 8.22 4.9 $ 322,929 Exercised (1,044,922) $ 7.36 $ 64,515 Canceled/forfeited/expired (20,667) $ 92.81 Outstanding as of July 31, 2023 3,735,027 $ 8.00 4.4 $ 246,235 Vested and expected to vest as of July 31, 2023 3,735,027 $ 8.00 4.4 $ 246,235 Exercisable as of July 31, 2023 3,734,578 $ 7.99 4.4 $ 246,235 As of July 31, 2023, unrecognized stock-based compensation expense related to outstanding unvested stock options was not material. Restricted Stock Units A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: RSUs RSUs Weighted- Unvested as of January 31, 2023 21,868,533 $ 109.31 Granted 13,450,561 $ 68.93 Vested (5,535,351) $ 110.16 Canceled/forfeited (2,946,033) $ 105.91 Unvested as of July 31, 2023 26,837,710 $ 89.28 As of July 31, 2023, unrecognized stock-based compensation expense related to RSUs was $2,091.1 million, which is expected to be recognized over a weighted-average period of 2.6 years. 2019 Employee Stock Purchase Plan In April 2019, we adopted the 2019 Employee Stock Purchase Plan (“ESPP”). As of July 31, 2023, unrecognized stock-based compensation expense related to the ESPP was $62.0 million, which is expected to be recognized over a weighted-average period of 1.4 years. Stock-Based Compensation The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 (in thousands) Cost of revenue $ 37,535 $ 37,177 $ 75,624 $ 68,327 Research and development 82,037 69,701 163,503 125,452 Sales and marketing 93,918 110,161 206,511 203,956 General and administrative 48,019 38,476 98,216 67,143 Total stock-based compensation expense $ 261,509 $ 255,515 $ 543,854 $ 464,878 Benefit from income taxes (48,766) (54,117) (98,443) (97,032) Total stock-based compensation expense recorded to net income $ 212,743 $ 201,398 $ 445,411 $ 367,846

Restructuring Activities

Restructuring Activities	6 Months Ended
Restructuring Activities	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring Activities	Restructuring Activities On February 7, 2023, we announced a restructuring plan (the “Plan”) intended to reduce operating costs and continue advancing our ongoing commitment to profitable growth. The Plan included a reduction of our current workforce by approximately 15%. For the three months ended July 31, 2023, we recorded net restructuring costs (benefits) of $(0.2) million, which consisted of $(0.4) million related to employee transition, severance payments, and employee benefits; and $0.2 million for other related expenses. For the six months ended July 31, 2023, we recorded net restructuring costs of $73.0 million, which consisted of $54.4 million related to employee transition, severance payments, and employee benefits; $17.3 million related to stock-based compensation awards; and $1.3 million for other related expenses. The execution of the Plan was completed as of July 31, 2023. The following table summarizes our restructuring expenses that were recorded as an operating expense in the condensed consolidated statement of operations for the three and six months ended July 31, 2023: Three Months Ended July 31, 2023 Six Months Ended July 31, 2023 (in thousands) Cost of revenue $ 24 $ 7,119 Research and development 327 19,629 Sales and marketing (911) 32,930 General and administrative 373 13,315 Total restructuring expenses $ (187) $ 72,993 The following table summarizes our restructuring liability that is included in accrued expenses and other current liabilities on the condensed consolidated balance sheet: Severance and termination benefits Other (in thousands) Balance as of January 31, 2023 $ — $ — Restructuring expenses 54,361 1,339 Cash payments (54,361) (1,339) Balance as of July 31, 2023 $ — $ —

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date ordinary income and adjust the provision for discrete tax items recorded in the period. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. The following table provides details of the provision for income taxes: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 (in thousands, except percentages) Income before provision for income taxes $ 250,373 $ 90,399 $ 293,603 $ 234,071 Provision for income taxes 68,399 44,649 96,185 74,663 Effective tax rate 27.3 % 49.4 % 32.8 % 31.9 % We had a provision for income taxes of $68.4 million and $44.6 million for the three months ended July 31, 2023 and 2022, respectively. The provision for income taxes was $96.2 million and $74.7 million for the six months ended July 31, 2023 and 2022, respectively. The year-over-year change in effective tax rate for the three and six months ended July 31, 2023 was due primarily to changes in the valuation allowance, tax shortfalls and windfalls on stock-based compensation, and the foreign-derived intangible income deduction. For both the three and six months ended July 31, 2023 and July 31, 2022, the effective tax rate differed from the U.S. federal statutory rate due primarily to the foreign-derived intangible income deduction and research credits, offset by tax shortfalls on stock-based compensation, the valuation allowance recorded on certain deferred tax assets, and other compensation-related permanent differences. During the three and six months ended July 31, 2023, there were no material changes to the total amount of unrecognized tax benefits and we do not expect any significant changes in the next 12 months. As required by the 2017 Tax Cuts and Jobs Act, we started capitalizing research and development expenses incurred beginning in fiscal year 2023. These expenses are capitalized and amortized over five years for domestic research and fifteen years for international research. The mandatory capitalization requirement increases our cash tax liabilities but also decreases our effective tax rate due to increasing the foreign-derived intangible income deduction. The cash flow impact will decrease over time as capitalized research and development expenditures continue to amortize. The Inflation Reduction Act was signed into law in August 2022. The act included tax provisions for a 15% corporate book income minimum tax effective for tax years beginning after December 31, 2022. We do not expect the Inflation Reduction Act to have a material impact on our consolidated financial statements.

Net Income Per Share Attributab

Net Income Per Share Attributable to Common Stockholders	6 Months Ended
Net Income Per Share Attributable to Common Stockholders	Jul. 31, 2023
Earnings Per Share [Abstract]
Net Income Per Share Attributable to Common Stockholders	Net Income Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B (in thousands, except share and per share data) Numerator: Net income $ 153,573 $ 28,401 $ 38,594 $ 7,156 $ 166,420 $ 30,998 $ 134,075 $ 25,333 Less: undistributed earnings attributable to participating securities — — — (4) — — — (19) Net income attributable to common stockholders, basic $ 153,573 $ 28,401 $ 38,594 $ 7,152 $ 166,420 $ 30,998 $ 134,075 $ 25,314 Reallocation of net income attributable to common stockholders (1,468) 1,468 (518) 518 (1,662) 1,662 (1,959) 1,959 Net income attributable to common stockholders, diluted $ 152,105 $ 29,869 $ 38,076 $ 7,670 $ 164,758 $ 32,660 $ 132,116 $ 27,273 Denominator: Weighted-average shares used in computing net income per share attributable to common stockholders, basic 252,413,018 46,680,434 251,878,556 46,674,823 250,603,102 46,678,744 251,400,283 47,465,393 Weighted-average shares used in computing net income per share attributable to common stockholders, diluted 255,717,521 50,215,075 255,661,184 51,499,656 254,587,009 50,467,762 254,389,537 52,513,427 Net income per share attributable to common stockholders, basic $ 0.61 $ 0.61 $ 0.15 $ 0.15 $ 0.66 $ 0.66 $ 0.53 $ 0.53 Net income per share attributable to common stockholders, diluted $ 0.59 $ 0.59 $ 0.15 $ 0.15 $ 0.65 $ 0.65 $ 0.52 $ 0.52 The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Unvested RSUs 9,214,305 — 6,451,823 — 10,083,918 — 5,113,608 — Purchase rights committed under the ESPP 2,347,590 — 1,757,812 — 2,208,209 — 995,341 — Outstanding stock options 108,647 — 103,406 — 116,349 — 51,703 — Total 11,670,542 — 8,313,041 — 12,408,476 — 6,160,652 — The table above does not include 405,156 shares of issued Class A common stock held by us as of July 31, 2023 and 2022 that are reserved for the sole purpose of being transferred to nonprofit organizations.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net income	$ 181,974	$ 45,750	$ 197,418	$ 159,408

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
Insider Trading Arrangements	Jul. 31, 2023 shares	Jul. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Trading Arrangements During the Company’s last fiscal quarter, the Company’s directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities set forth in the table below. Type of Trading Arrangement Name and Position Action Adoption/ Termination Date Rule 10b5-1* Non- Rule 10b5-1 Total Shares of Class A Common Stock to be Sold* Expiration Date Aparna Bawa, Chief Operating Officer Adoption 06/21/2023 X 166,944 07/31/2024 Velchamy Sankarlingam, President of Product & Engineering Adoption 06/15/2023 X 109,965 08/23/2024 Eric S. Yuan, Chief Executive Officer Adoption 06/02/2023 X 156,680 10/18/2024 * Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. * Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The actual number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the written plan.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Aparna Bawa [Member]
Trading Arrangements, by Individual
Name	Aparna Bawa
Title	Chief Operating Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	06/21/2023
Arrangement Duration	406 days
Aggregate Available	166,944	166,944
Velchamy Sankarlingam [Member]
Trading Arrangements, by Individual
Name	Velchamy Sankarlingam
Title	President of Product & Engineering
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	06/15/2023
Arrangement Duration	435 days
Aggregate Available	109,965	109,965
Eric S. Yuan [Member]
Trading Arrangements, by Individual
Name	Eric S. Yuan
Title	Chief Executive Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	06/02/2023
Arrangement Duration	504 days
Aggregate Available	156,680	156,680

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, stock-based compensation expense, the fair value of marketable securities, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
Revenue Recognition (Tables)	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Region	The following table summarizes revenue by region based on the billing address of customers: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Amount Percentage of Amount Percentage of Amount Percentage of Amount Percentage of (in thousands, except percentages) Americas $ 808,425 71 % $ 762,690 69 % $ 1,593,022 71 % $ 1,491,071 69 % Asia Pacific (“APAC”) 144,915 13 149,355 14 285,786 13 298,175 14 Europe, Middle East, and Africa (“EMEA”) 185,336 16 187,413 17 365,232 16 384,012 17 Total $ 1,138,676 100 % $ 1,099,458 100 % $ 2,244,040 100 % $ 2,173,258 100 %

Investments (Tables)

Investments (Tables)	6 Months Ended
Investments (Tables)	Jul. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	As of July 31, 2023 and January 31, 2023, our marketable securities consisted of the following: As of July 31, 2023 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 67,269 $ — $ — $ 67,269 Agency bonds 1,445,880 7 (15,588) 1,430,299 Corporate and other debt securities 543,042 68 (4,635) 538,475 U.S. government agency securities 2,590,023 10 (28,254) 2,561,779 Treasury bills 50,596 — (25) 50,571 Marketable securities $ 4,696,810 $ 85 $ (48,502) $ 4,648,393 As of January 31, 2023 Amortized Gross Gross Estimated (in thousands) Commercial paper $ 77,701 $ — $ — $ 77,701 Agency bonds 823,027 63 (12,440) 810,650 Corporate and other debt securities 555,354 385 (4,845) 550,894 U.S. government agency securities 2,910,572 150 (49,507) 2,861,215 Treasury bills 25,404 1 (29) 25,376 Marketable securities $ 4,392,058 $ 599 $ (66,821) $ 4,325,836
Schedule of Contractual Maturities of Marketable Securities	The following table presents the contractual maturities of our marketable securities as of July 31, 2023 and January 31, 2023: As of July 31, 2023 January 31, 2023 (in thousands) Less than one year $ 2,757,001 $ 2,743,677 Due in one to five years 1,891,392 1,582,159 Total $ 4,648,393 $ 4,325,836
Schedule of Strategic Investments	Strategic investments by form and measurement category as of July 31, 2023 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 92,139 $ 185,732 $ 95,070 $ 372,941 Debt securities 3,752 — — 3,752 Strategic investments $ 95,891 $ 185,732 $ 95,070 $ 376,693 Strategic investments by form and measurement category as of January 31, 2023 were as follows: Measurement Category Fair Value Measurement Alternative Equity Method Total (in thousands) Equity securities $ 171,975 $ 118,763 $ 93,854 $ 384,592 Debt securities 14,400 — — 14,400 Strategic investments $ 186,375 $ 118,763 $ 93,854 $ 398,992

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
Fair Value Measurements (Tables)	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value: As of July 31, 2023 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 801,409 $ 801,409 $ — $ — Treasury bills 71,187 — 71,187 — Cash equivalents 872,596 801,409 71,187 — Commercial paper 67,269 — 67,269 — Agency bonds 1,430,299 — 1,430,299 — Corporate and other debt securities 538,475 — 538,475 — U.S. government agency securities 2,561,779 — 2,561,779 — Treasury bills 50,571 — 50,571 — Marketable securities 4,648,393 — 4,648,393 — Certificates of deposit included in other assets, noncurrent 255 — 255 — Publicly held equity securities included in strategic investments 92,139 92,139 — — Privately held debt securities included in strategic investments 3,752 — — 3,752 Total financial assets $ 5,617,135 $ 893,548 $ 4,719,835 $ 3,752 As of January 31, 2023 Fair Value Level 1 Level 2 Level 3 (in thousands) Financial Assets: Money market funds $ 310,571 $ 310,571 $ — $ — Cash equivalents 310,571 310,571 — — Commercial paper 77,701 — 77,701 — Agency bonds 810,650 — 810,650 — Corporate and other debt securities 550,894 — 550,894 — U.S. government agency securities 2,861,215 — 2,861,215 — Treasury bills 25,376 — 25,376 — Marketable securities 4,325,836 — 4,325,836 — Certificates of deposit included in other assets, noncurrent 272 — 272 — Publicly held equity securities included in strategic investments 171,975 171,975 — — Privately held debt securities included in strategic investments 14,400 — — 14,400 Total financial assets $ 4,823,054 $ 482,546 $ 4,326,108 $ 14,400

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
Balance Sheet Components (Tables)	Jul. 31, 2023
Balance Sheet Components [Abstract]
Schedule of Accounts Receivable	Our short-term accounts receivable consist of the following: As of July 31, 2023 January 31, 2023 (in thousands) Accounts receivable, gross $ 616,830 $ 590,610 Less: allowance for credit losses (38,093) (24,900) Less: allowance for returns (7,688) (8,306) Accounts receivable, net $ 571,049 $ 557,404
Schedule of Allowance for Credit Loss	Below is a rollforward of our allowance for credit losses for the six months ended July 31, 2023 and 2022: 2023 2022 (in thousands) Balance as of January 31 $ 24,900 $ 17,000 Provision for credit losses 30,250 25,606 Write-offs (17,057) (19,406) Balance as of July 31 $ 38,093 $ 23,200
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Prepaid expenses $ 204,768 $ 123,493 Other receivables 16,427 17,142 Restricted cash from international employee stock sales 11,856 13,141 Other 11,213 9,316 Prepaid expenses and other current assets $ 244,264 $ 163,092
Schedule of Property and Equipment	Property and equipment consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Servers $ 303,527 $ 249,776 Software 89,872 84,082 Computer and office equipment 46,780 48,325 Leasehold improvements 30,863 25,948 Furniture and fixtures 4,449 4,372 Property and equipment, gross 475,491 412,503 Less: accumulated depreciation and amortization (199,610) (159,682) Property and equipment, net $ 275,881 $ 252,821
Schedule of Other Assets, Noncurrent	Other assets, noncurrent consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Accounts receivable, noncurrent $ 41,820 $ 92,031 Intangible assets subject to amortization, net 53,832 31,420 Indefinite-lived intangible assets 25,239 25,239 Prepaid expenses, noncurrent 17,528 9,695 Other 12,303 19,489 Other assets, noncurrent $ 150,722 $ 177,874
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Accrued expenses $ 151,881 $ 160,189 Accrued compensation and benefits 111,791 139,105 Income tax liabilities 20,224 46,441 Sales and other non-income tax liabilities 30,968 33,859 Customer deposit liabilities 35,236 33,640 Operating lease liabilities, current 23,512 22,790 Other 23,656 21,692 Accrued expenses and other current liabilities $ 397,268 $ 457,716
Schedule of Other Liabilities, Noncurrent	Other liabilities, noncurrent consisted of the following: As of July 31, 2023 January 31, 2023 (in thousands) Sales and other non-income tax liabilities $ 43,640 $ 42,321 Other 27,045 24,874 Other liabilities, noncurrent $ 70,685 $ 67,195

Stockholders_ Equity and Equi_2

Stockholders’ Equity and Equity Incentive Plans (Tables)	6 Months Ended
Stockholders’ Equity and Equity Incentive Plans (Tables)	Jul. 31, 2023
Stockholders' Equity Note [Abstract]
Schedule of Stock Option Activity Under Equity Incentive Plan	A summary of stock option activity under our equity incentive plan and related information is as follows: Stock Options Outstanding Weighted- Weighted- Aggregate (in thousands, except share, life, and per share data) Balance as of January 31, 2023 4,800,616 $ 8.22 4.9 $ 322,929 Exercised (1,044,922) $ 7.36 $ 64,515 Canceled/forfeited/expired (20,667) $ 92.81 Outstanding as of July 31, 2023 3,735,027 $ 8.00 4.4 $ 246,235 Vested and expected to vest as of July 31, 2023 3,735,027 $ 8.00 4.4 $ 246,235 Exercisable as of July 31, 2023 3,734,578 $ 7.99 4.4 $ 246,235
Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan	A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows: RSUs RSUs Weighted- Unvested as of January 31, 2023 21,868,533 $ 109.31 Granted 13,450,561 $ 68.93 Vested (5,535,351) $ 110.16 Canceled/forfeited (2,946,033) $ 105.91 Unvested as of July 31, 2023 26,837,710 $ 89.28
Schedule of Stock-based Compensation Expense by Line Item	The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 (in thousands) Cost of revenue $ 37,535 $ 37,177 $ 75,624 $ 68,327 Research and development 82,037 69,701 163,503 125,452 Sales and marketing 93,918 110,161 206,511 203,956 General and administrative 48,019 38,476 98,216 67,143 Total stock-based compensation expense $ 261,509 $ 255,515 $ 543,854 $ 464,878 Benefit from income taxes (48,766) (54,117) (98,443) (97,032) Total stock-based compensation expense recorded to net income $ 212,743 $ 201,398 $ 445,411 $ 367,846

Restructuring Activities (Table

Restructuring Activities (Tables)	6 Months Ended
Restructuring Activities (Tables)	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Costs	The following table summarizes our restructuring expenses that were recorded as an operating expense in the condensed consolidated statement of operations for the three and six months ended July 31, 2023: Three Months Ended July 31, 2023 Six Months Ended July 31, 2023 (in thousands) Cost of revenue $ 24 $ 7,119 Research and development 327 19,629 Sales and marketing (911) 32,930 General and administrative 373 13,315 Total restructuring expenses $ (187) $ 72,993
Schedule of Restructuring Reserve by Type of Cost	The following table summarizes our restructuring liability that is included in accrued expenses and other current liabilities on the condensed consolidated balance sheet: Severance and termination benefits Other (in thousands) Balance as of January 31, 2023 $ — $ — Restructuring expenses 54,361 1,339 Cash payments (54,361) (1,339) Balance as of July 31, 2023 $ — $ —

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
Income Taxes (Tables)	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes	The following table provides details of the provision for income taxes: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 (in thousands, except percentages) Income before provision for income taxes $ 250,373 $ 90,399 $ 293,603 $ 234,071 Provision for income taxes 68,399 44,649 96,185 74,663 Effective tax rate 27.3 % 49.4 % 32.8 % 31.9 %

Net Income Per Share Attribut_2

Net Income Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Income Per Share	The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B (in thousands, except share and per share data) Numerator: Net income $ 153,573 $ 28,401 $ 38,594 $ 7,156 $ 166,420 $ 30,998 $ 134,075 $ 25,333 Less: undistributed earnings attributable to participating securities — — — (4) — — — (19) Net income attributable to common stockholders, basic $ 153,573 $ 28,401 $ 38,594 $ 7,152 $ 166,420 $ 30,998 $ 134,075 $ 25,314 Reallocation of net income attributable to common stockholders (1,468) 1,468 (518) 518 (1,662) 1,662 (1,959) 1,959 Net income attributable to common stockholders, diluted $ 152,105 $ 29,869 $ 38,076 $ 7,670 $ 164,758 $ 32,660 $ 132,116 $ 27,273 Denominator: Weighted-average shares used in computing net income per share attributable to common stockholders, basic 252,413,018 46,680,434 251,878,556 46,674,823 250,603,102 46,678,744 251,400,283 47,465,393 Weighted-average shares used in computing net income per share attributable to common stockholders, diluted 255,717,521 50,215,075 255,661,184 51,499,656 254,587,009 50,467,762 254,389,537 52,513,427 Net income per share attributable to common stockholders, basic $ 0.61 $ 0.61 $ 0.15 $ 0.15 $ 0.66 $ 0.66 $ 0.53 $ 0.53 Net income per share attributable to common stockholders, diluted $ 0.59 $ 0.59 $ 0.15 $ 0.15 $ 0.65 $ 0.65 $ 0.52 $ 0.52
Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders	The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows: Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Unvested RSUs 9,214,305 — 6,451,823 — 10,083,918 — 5,113,608 — Purchase rights committed under the ESPP 2,347,590 — 1,757,812 — 2,208,209 — 995,341 — Outstanding stock options 108,647 — 103,406 — 116,349 — 51,703 — Total 11,670,542 — 8,313,041 — 12,408,476 — 6,160,652 —

Revenue Recognition - Summary D

Revenue Recognition - Summary Disaggregation of Revenue by Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 1,138,676	$ 1,099,458	$ 2,244,040	$ 2,173,258
Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	100%	100%	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Revenue	$ 808,425	$ 762,690	$ 1,593,022	$ 1,491,071
Americas \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	71%	69%	71%	69%
Asia Pacific (“APAC”)
Disaggregation of Revenue [Line Items]
Revenue	$ 144,915	$ 149,355	$ 285,786	$ 298,175
Asia Pacific (“APAC”) \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	13%	14%	13%	14%
Europe, Middle East, and Africa (“EMEA”)
Disaggregation of Revenue [Line Items]
Revenue	$ 185,336	$ 187,413	$ 365,232	$ 384,012
Europe, Middle East, and Africa (“EMEA”) \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	16%	17%	16%	17%

Revenue Recognition - Contract

Revenue Recognition - Contract Balances (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Unbilled contracts receivable	$ 115.6		$ 115.6		$ 91.6
Revenue recognized included in deferred revenue	$ 593.9	$ 572.7	$ 939.2	$ 867.6

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligation (Details) $ in Millions	Jul. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 3,504.4
Billed Consideration
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	1,369.8
Unbilled Consideration
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 2,134.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as a percent)	59%
Revenue remaining performance obligation, expected timing of satisfaction period (in months)	12 months

Investments - Summary of Market

Investments - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Marketable Securities [Line Items]
Amortized Cost	$ 4,696,810	$ 4,392,058
Gross Unrealized Gains	85	599
Gross Unrealized Losses	(48,502)	(66,821)
Estimated Fair Value	4,648,393	4,325,836
Commercial paper
Marketable Securities [Line Items]
Amortized Cost	67,269	77,701
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	67,269	77,701
Agency bonds
Marketable Securities [Line Items]
Amortized Cost	1,445,880	823,027
Gross Unrealized Gains	7	63
Gross Unrealized Losses	(15,588)	(12,440)
Estimated Fair Value	1,430,299	810,650
Corporate and other debt securities
Marketable Securities [Line Items]
Amortized Cost	543,042	555,354
Gross Unrealized Gains	68	385
Gross Unrealized Losses	(4,635)	(4,845)
Estimated Fair Value	538,475	550,894
U.S. government agency securities
Marketable Securities [Line Items]
Amortized Cost	2,590,023	2,910,572
Gross Unrealized Gains	10	150
Gross Unrealized Losses	(28,254)	(49,507)
Estimated Fair Value	2,561,779	2,861,215
Treasury bills
Marketable Securities [Line Items]
Amortized Cost	50,596	25,404
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(25)	(29)
Estimated Fair Value	$ 50,571	$ 25,376

Investments - Additional Inform

Investments - Additional Information (Details) - USD ($)	3 Months Ended			6 Months Ended
Investments - Additional Information (Details) - USD ($)	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Net Investment Income [Line Items]
Unrealized losses for securities in unrealized loss position for less than 12 months	$ 25,200,000			$ 25,200,000		$ 24,800,000
Unrealized losses for securities in unrealized loss position for 12 months or longer	23,300,000			23,300,000		$ 42,000,000
Available-for-sale, realized gain (loss)	0		$ 0	0	$ 0
Purchase of strategic investments				51,000,000	61,550,000
Proceeds from strategic investments				$ 107,244,000	$ 0
Investment in Equity Securities of Private Companies
Net Investment Income [Line Items]
Purchase of strategic investments		$ 51,000,000
Investment in Equity Securities of Public Companies
Net Investment Income [Line Items]
Proceeds from strategic investments	$ 107,200,000

Investments - Summary of Contra

Investments - Summary of Contractual Maturities of Marketable Securities (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Less than one year	$ 2,757,001	$ 2,743,677
Due in one to five years	1,891,392	1,582,159
Total	$ 4,648,393	$ 4,325,836

Investments - Schedule of Strat

Investments - Schedule of Strategic Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement Alternative	$ 185,732	$ 118,763
Equity Method	95,070	93,854
Total equity securities	372,941	384,592
Debt securities	3,752	14,400
Fair value of strategic investments	95,891	186,375
Total strategic investments	376,693	398,992
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities	92,139	171,975
Debt securities	$ 3,752	$ 14,400

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Financial Assets:
Marketable securities	$ 4,648,393	$ 4,325,836
Commercial paper
Financial Assets:
Marketable securities	67,269	77,701
Agency bonds
Financial Assets:
Marketable securities	1,430,299	810,650
Corporate and other debt securities
Financial Assets:
Marketable securities	538,475	550,894
U.S. government agency securities
Financial Assets:
Marketable securities	2,561,779	2,861,215
Fair Value, Recurring Basis
Financial Assets:
Cash equivalents	872,596	310,571
Marketable securities	4,648,393	4,325,836
Publicly held equity securities included in strategic investments	92,139	171,975
Total financial assets	5,617,135	4,823,054
Fair Value, Recurring Basis \| Commercial paper
Financial Assets:
Marketable securities	67,269	77,701
Fair Value, Recurring Basis \| Agency bonds
Financial Assets:
Marketable securities	1,430,299	810,650
Fair Value, Recurring Basis \| Corporate and other debt securities
Financial Assets:
Marketable securities	538,475	550,894
Fair Value, Recurring Basis \| U.S. government agency securities
Financial Assets:
Marketable securities	2,561,779	2,861,215
Fair Value, Recurring Basis \| Treasury bills
Financial Assets:
Marketable securities	50,571	25,376
Fair Value, Recurring Basis \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	255	272
Fair Value, Recurring Basis \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	3,752	14,400
Fair Value, Recurring Basis \| Money market funds
Financial Assets:
Cash equivalents	801,409	310,571
Fair Value, Recurring Basis \| Treasury bills
Financial Assets:
Cash equivalents	71,187
Fair Value, Recurring Basis \| Level 1
Financial Assets:
Cash equivalents	801,409	310,571
Marketable securities	0	0
Publicly held equity securities included in strategic investments	92,139	171,975
Total financial assets	893,548	482,546
Fair Value, Recurring Basis \| Level 1 \| Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis \| Level 1 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Money market funds
Financial Assets:
Cash equivalents	801,409	310,571
Fair Value, Recurring Basis \| Level 1 \| Treasury bills
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis \| Level 2
Financial Assets:
Cash equivalents	71,187	0
Marketable securities	4,648,393	4,325,836
Publicly held equity securities included in strategic investments	0	0
Total financial assets	4,719,835	4,326,108
Fair Value, Recurring Basis \| Level 2 \| Commercial paper
Financial Assets:
Marketable securities	67,269	77,701
Fair Value, Recurring Basis \| Level 2 \| Agency bonds
Financial Assets:
Marketable securities	1,430,299	810,650
Fair Value, Recurring Basis \| Level 2 \| Corporate and other debt securities
Financial Assets:
Marketable securities	538,475	550,894
Fair Value, Recurring Basis \| Level 2 \| U.S. government agency securities
Financial Assets:
Marketable securities	2,561,779	2,861,215
Fair Value, Recurring Basis \| Level 2 \| Treasury bills
Financial Assets:
Marketable securities	50,571	25,376
Fair Value, Recurring Basis \| Level 2 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	255	272
Fair Value, Recurring Basis \| Level 2 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 2 \| Money market funds
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 2 \| Treasury bills
Financial Assets:
Cash equivalents	71,187
Fair Value, Recurring Basis \| Level 3
Financial Assets:
Cash equivalents	0	0
Marketable securities	0	0
Publicly held equity securities included in strategic investments	0	0
Total financial assets	3,752	14,400
Fair Value, Recurring Basis \| Level 3 \| Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis \| Level 3 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	3,752	14,400
Fair Value, Recurring Basis \| Level 3 \| Money market funds
Financial Assets:
Cash equivalents	0	$ 0
Fair Value, Recurring Basis \| Level 3 \| Treasury bills
Financial Assets:
Cash equivalents	$ 0

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands			6 Months Ended
Business Combinations (Details) - USD ($) $ in Thousands	Apr. 21, 2023	May 19, 2022	Jul. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Goodwill			$ 307,295	$ 122,641
Solvvy, Inc.
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired (as a percent)		100%
Cash consideration paid		$ 121,200
Goodwill		95,000
Intangible assets, other than goodwill		26,700
Other net liabilities acquired		(500)
Solvvy, Inc. \| Developed Technology Rights
Business Acquisition [Line Items]
Intangible assets, other than goodwill		$ 12,000
Acquired finite-lived intangible assets, weighted average useful life (in years)		5 years	3 years 9 months 18 days
Solvvy, Inc. \| Customer Relationships
Business Acquisition [Line Items]
Intangible assets, other than goodwill		$ 14,700
Acquired finite-lived intangible assets, weighted average useful life (in years)		5 years	3 years 9 months 18 days
Workvivo Limited
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired (as a percent)	100%
Cash consideration paid	$ 221,800
Goodwill			$ 184,700
Intangible assets, other than goodwill			28,000
Other net assets acquired			9,100
Workvivo Limited \| Developed Technology Rights
Business Acquisition [Line Items]
Intangible assets, other than goodwill			$ 10,800
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years		4 years 8 months 12 days
Workvivo Limited \| Customer Relationships
Business Acquisition [Line Items]
Intangible assets, other than goodwill			$ 17,000
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years		4 years 8 months 12 days

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023	Jul. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Accounts receivable, gross	$ 616,830	$ 590,610
Less: allowance for credit losses	(38,093)	(24,900)	$ (23,200)	$ (17,000)
Less: allowance for returns	(7,688)	(8,306)
Accounts receivable, net	$ 571,049	$ 557,404

Balance Sheet Components - Roll

Balance Sheet Components - Rollforward of Allowance For Credit Losses (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 24,900	$ 17,000
Provision for credit losses	30,250	25,606
Write-offs	(17,057)	(19,406)
Ending balance	$ 38,093	$ 23,200

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Prepaid expenses	$ 204,768	$ 123,493
Other receivables	16,427	17,142
Restricted cash from international employee stock sales	11,856	13,141
Other	11,213	9,316
Prepaid expenses and other current assets	$ 244,264	$ 163,092

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Property and Equipment Net (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 475,491	$ 412,503
Less: accumulated depreciation and amortization	(199,610)	(159,682)
Property and equipment, net	275,881	252,821
Servers
Property, Plant and Equipment [Line Items]
Property and equipment, gross	303,527	249,776
Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	89,872	84,082
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	46,780	48,325
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	30,863	25,948
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 4,449	$ 4,372

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Balance Sheet Components [Abstract]
Depreciation and amortization expense	$ 22.6	$ 19.6	$ 44.6	$ 34.7

Balance Sheet Components - Othe

Balance Sheet Components - Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Accounts receivable, noncurrent	$ 41,820	$ 92,031
Intangible assets subject to amortization, net	53,832	31,420
Indefinite-lived intangible assets	25,239	25,239
Prepaid expenses, noncurrent	17,528	9,695
Other	12,303	19,489
Other assets, noncurrent	$ 150,722	$ 177,874

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Accrued expenses	$ 151,881	$ 160,189
Accrued compensation and benefits	111,791	139,105
Income tax liabilities	20,224	46,441
Sales and other non-income tax liabilities	30,968	33,859
Customer deposit liabilities	35,236	33,640
Operating lease liabilities, current	23,512	22,790
Other	23,656	21,692
Accrued expenses and other current liabilities	$ 397,268	$ 457,716

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Other Liabilities Non Current (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Sales and other non-income tax liabilities	$ 43,640	$ 42,321
Other	27,045	24,874
Other liabilities, noncurrent	$ 70,685	$ 67,195

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions

3 Months Ended

6 Months Ended

Jul. 25, 2023 USD ($)

Oct. 17, 2022 objector

May 19, 2022 objector

Oct. 21, 2021 USD ($)

Jul. 30, 2020 officer

Jun. 11, 2020 officer

Apr. 08, 2020 officer

Jul. 31, 2023 USD ($)

Jul. 17, 2023 USD ($)

Jan. 31, 2023 USD ($)

Nov. 17, 2021 lawsuit

Other Commitments [Line Items]

Number of derivative lawsuits | lawsuit

Pending Litigation | Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5

Other Commitments [Line Items]

Amount of payment agreed upon

$ 150

Settled Litigation | Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5

Other Commitments [Line Items]

Payments for legal settlements

$ 60

Payments for legal settlements, gross

150

Payments for legal settlements, net of insurance payment

$ 90

Loss contingency accrual

$ 7.5

Aggregate legal settlement charge

$ 0

$ 52.5

U.S. Privacy Class Actions

Other Commitments [Line Items]

Loss contingency, number of defendants | objector

Payments for legal settlements

$ 85

Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5

Other Commitments [Line Items]

Loss contingency, number of defendants | officer

Stockholders_ Equity and Equi_3

Stockholders’ Equity and Equity Incentive Plans - Additional Information (Details)	3 Months Ended	6 Months Ended
	Jul. 31, 2022 USD ($) shares	Jul. 31, 2023 USD ($) plan $ / shares shares	Jul. 31, 2022 USD ($) shares	Jan. 31, 2023 $ / shares shares	Feb. 28, 2022 USD ($)
Class of Stock [Line Items]
Common stock, par value (in dollars per share) \| $ / shares		$ 0.001		$ 0.001
Stock repurchase plan, authorized amount (up to) \| $					$ 1,000,000,000
Number of equity incentive plans \| plan		2
RSUs
Class of Stock [Line Items]
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		2 years 7 months 6 days
Unrecognized stock-based compensation expenses \| $		$ 2,091,100,000
Employee Stock Purchase Plan
Class of Stock [Line Items]
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		1 year 4 months 24 days
Unrecognized stock-based compensation expenses \| $		$ 62,000,000
Class A Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares)		2,000,000,000		2,000,000,000
Stock repurchased and retired during period (in shares)	2,864,721		4,088,971
Stock repurchased and retired during period \| $	$ 293,500,000		$ 425,900,000
Class A Common Stock \| Initial Public Offering
Class of Stock [Line Items]
Common stock, authorized (in shares)		2,000,000,000
Common stock, par value (in dollars per share) \| $ / shares		$ 0.001
Class B Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares)		300,000,000		300,000,000
Class B Common Stock \| Initial Public Offering
Class of Stock [Line Items]
Common stock, authorized (in shares)		300,000,000
Common stock, par value (in dollars per share) \| $ / shares		$ 0.001

Stockholders_ Equity and Equi_4

Stockholders’ Equity and Equity Incentive Plans - Summary of Stock Option Activity Under Equity Incentive Plan (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares
Outstanding Stock Options
Beginning balance (in shares) \| shares	4,800,616
Exercised (in shares) \| shares	(1,044,922)
Cancelled/forfeited/expired (in shares) \| shares	(20,667)
Ending balance (in shares) \| shares	3,735,027	4,800,616
Vested and expected to vest (in shares) \| shares	3,735,027
Exercisable (in shares) \| shares	3,734,578
Weighted- Average Exercise Price
Beginning balance (in dollars per share) \| $ / shares	$ 8.22
Exercised (in dollars per share) \| $ / shares	7.36
Cancelled/forfeited/expired (in dollars per share) \| $ / shares	92.81
Ending balance (in dollars per share) \| $ / shares	8	$ 8.22
Weighted average exercise price, vested and expected to vest (in dollars per share) \| $ / shares	8
Weighted average exercise price, exercisable (in dollars per share) \| $ / shares	$ 7.99
Weighted- Average Remaining Contractual Life (Years)
Outstanding (in years)	4 years 4 months 24 days	4 years 10 months 24 days
Vested and expected to vest (in years)	4 years 4 months 24 days
Weighted-average remaining contractual life, exercisable (in years)	4 years 4 months 24 days
Aggregate Intrinsic Value
Outstanding \| $	$ 246,235	$ 322,929
Exercised \| $	64,515
Vested and expected to vest \| $	246,235
Aggregate intrinsic value, exercisable \| $	$ 246,235

Stockholders_ Equity and Equi_5

Stockholders’ Equity and Equity Incentive Plans - Summary of Restricted Stock Units Activity Under Equity Incentive Plan (Details) - RSUs	6 Months Ended
	Jul. 31, 2023 $ / shares shares
RSUs
Beginning balance (in shares) \| shares	21,868,533
Granted (in shares) \| shares	13,450,561
Vested (in shares) \| shares	(5,535,351)
Cancelled/forfeited (in shares) \| shares	(2,946,033)
Ending balance (in shares) \| shares	26,837,710
Weighted- Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 109.31
Granted (in dollars per share) \| $ / shares	68.93
Vested (in dollars per share) \| $ / shares	110.16
Cancelled/forfeited (in dollars per share) \| $ / shares	105.91
Ending balance (in dollars per share) \| $ / shares	$ 89.28

Stockholders_ Equity and Equi_6

Stockholders’ Equity and Equity Incentive Plans - Summary of Stock-based Compensation Expense by Line Item (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 261,509	$ 255,515	$ 543,854	$ 464,878
Benefit from income taxes	(48,766)	(54,117)	(98,443)	(97,032)
Total stock-based compensation expense recorded to net income	212,743	201,398	445,411	367,846
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	37,535	37,177	75,624	68,327
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	82,037	69,701	163,503	125,452
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	93,918	110,161	206,511	203,956
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 48,019	$ 38,476	$ 98,216	$ 67,143

Restructuring Activities - Addi

Restructuring Activities - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	Feb. 07, 2023	Jul. 31, 2023	Jul. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring costs (benefits)		$ (187)	$ 72,993
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring costs (benefits)		(400)	54,400
Other Related Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring costs (benefits)		$ 200	1,300
Employee Stock-Based Compensation Awards
Restructuring Cost and Reserve [Line Items]
Restructuring costs (benefits)			$ 17,300
The Plan
Restructuring Cost and Reserve [Line Items]
Reduction in current workforce	15%

Restructuring Activities - Rest

Restructuring Activities - Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	$ (187)	$ 72,993
Cost of revenue
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	24	7,119
Research and development
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	327	19,629
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	(911)	32,930
General and administrative
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	$ 373	$ 13,315

Restructuring Activities - Sche

Restructuring Activities - Schedule of Restructuring Reserve (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jan. 31, 2023
Severance and termination benefits
Restructuring Reserve [Roll Forward]
Restructuring reserve, balance at end of period	$ 0	$ 0
Restructuring expenses	54,361
Cash payments	(54,361)
Other
Restructuring Reserve [Roll Forward]
Restructuring reserve, balance at end of period	0	$ 0
Restructuring expenses	1,339
Cash payments	$ (1,339)

Income Taxes - Provision for In

Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 250,373	$ 90,399	$ 293,603	$ 234,071
Provision for income taxes	$ 68,399	$ 44,649	$ 96,185	$ 74,663
Effective tax rate	27.30%	49.40%	32.80%	31.90%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 68,399	$ 44,649	$ 96,185	$ 74,663

Net Income Per Share Attribut_3

Net Income Per Share Attributable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Numerator:
Net income	$ 181,974	$ 45,750	$ 197,418	$ 159,408
Net income attributable to common stockholders	$ 181,974	$ 45,746	$ 197,418	$ 159,389
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	299,093,452	298,553,379	297,281,846	298,865,676
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	305,932,596	307,160,840	305,054,771	306,902,964
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.61	$ 0.15	$ 0.66	$ 0.53
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.59	$ 0.15	$ 0.65	$ 0.52
Class A
Numerator:
Net income	$ 153,573	$ 38,594	$ 166,420	$ 134,075
Less: undistributed earnings attributable to participating securities	0	0	0	0
Net income attributable to common stockholders	153,573	38,594	166,420	134,075
Reallocation of net income attributable to common stockholders	(1,468)	(518)	(1,662)	(1,959)
Net income attributable to common stockholders, diluted	$ 152,105	$ 38,076	$ 164,758	$ 132,116
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	252,413,018	251,878,556	250,603,102	251,400,283
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	255,717,521	255,661,184	254,587,009	254,389,537
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.61	$ 0.15	$ 0.66	$ 0.53
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.59	$ 0.15	$ 0.65	$ 0.52
Class B
Numerator:
Net income	$ 28,401	$ 7,156	$ 30,998	$ 25,333
Less: undistributed earnings attributable to participating securities	0	(4)	0	(19)
Net income attributable to common stockholders	28,401	7,152	30,998	25,314
Reallocation of net income attributable to common stockholders	1,468	518	1,662	1,959
Net income attributable to common stockholders, diluted	$ 29,869	$ 7,670	$ 32,660	$ 27,273
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	46,680,434	46,674,823	46,678,744	47,465,393
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	50,215,075	51,499,656	50,467,762	52,513,427
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.61	$ 0.15	$ 0.66	$ 0.53
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.59	$ 0.15	$ 0.65	$ 0.52

Net Income Per Share Attribut_4

Net Income Per Share Attributable to Common Stockholders - Summary of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders (Details) - shares	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	11,670,542	8,313,041	12,408,476	6,160,652
Class A \| Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	9,214,305	6,451,823	10,083,918	5,113,608
Class A \| Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	2,347,590	1,757,812	2,208,209	995,341
Class A \| Outstanding stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	108,647	103,406	116,349	51,703
Class A \| Held For Charitable Contributions
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)			405,156	405,156
Class B
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B \| Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B \| Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B \| Outstanding stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0